Department of Oncology, Nantong First People's Hospital and Second Affiliated Hospital of Nantong University, 666 Shengli Road, Chongchuan District, Nantong City, Jiangsu, China.
Department of Oncology, Nantong First People's Hospital and Second Affiliated Hospital of Nantong University, 666 Shengli Road, Chongchuan District, Nantong City, Jiangsu, China.
Pathol Res Pract. 2024 Dec;264:155673. doi: 10.1016/j.prp.2024.155673. Epub 2024 Oct 24.
The dysregulation of circular RNAs (circRNAs) is closely associated with the pathogenesis of colorectal cancer (CRC). The present study aimed to elucidate the biological function and mechanism of circ_0060927 in CRC.
5-ethynyl-2'-deoxyuridine, Cell Counting Kit-8 (CCK-8), flow cytometry and transwell assays, as well as Xenograft tumor models were adopted for in vitro and in vivo analyses. The interaction between microRNA-331-3p (miR-331-3p) and circ_0060927 or T-box transcription factor 2 (TBX2) was verified by the dual-luciferase reporter and RNA pull-down assays.
Circ_0060927 deficiency inhibited cell proliferation, autophagy, migration, and invasion and increased cell apoptosis and necrosis in CRC cells, as well as inhibited tumor growth in vivo. Circ_0060927 could bind to miR-331-3p, and circ_0060927 regulated CRC cell behaviors via sponging miR-331-3p. TBX2 was targeted by miR-331-3p, and miR-331-3p targeted TBX2 to exert the anti-cancer role in CRC cells. Mechanically, circ_0060927 regulated TBX2 expression by sequestering miR-331-3p in CRC cells.
Circ_0060927 downregulation inhibited CRC progression by regulating the miR-331-3p/TBX2 axis, which might offer a potential treatment target for CRC.
环状 RNA(circRNAs)的失调与结直肠癌(CRC)的发病机制密切相关。本研究旨在阐明 circ_0060927 在 CRC 中的生物学功能和机制。
采用 5-乙炔基-2'-脱氧尿苷、细胞计数试剂盒-8(CCK-8)、流式细胞术和 Transwell 测定以及异种移植肿瘤模型进行体外和体内分析。通过双荧光素酶报告和 RNA 下拉测定验证 microRNA-331-3p(miR-331-3p)与 circ_0060927 或 T 盒转录因子 2(TBX2)之间的相互作用。
circ_0060927 缺失抑制 CRC 细胞的增殖、自噬、迁移和侵袭,并增加细胞凋亡和坏死,同时抑制体内肿瘤生长。circ_0060927 可以与 miR-331-3p 结合,并且 circ_0060927 通过海绵 miR-331-3p 调节 CRC 细胞行为。TBX2 是 miR-331-3p 的靶标,miR-331-3p 通过靶向 TBX2 在 CRC 细胞中发挥抗癌作用。机制上,circ_0060927 通过在 CRC 细胞中隔离 miR-331-3p 来调节 TBX2 的表达。
circ_0060927 的下调通过调节 miR-331-3p/TBX2 轴抑制 CRC 进展,这可能为 CRC 提供潜在的治疗靶点。